Similar drugsTo uncover
Dosage form: & nbspsolution for injection and topical application
Composition:
The active substance is dioxidine 5 g.
Excipients - water for injection up to 1 liter.
Description:Light yellow transparent liquid with a greenish tinge.
Pharmacotherapeutic group:Antimicrobial agent, quinoxaline
ATX: & nbsp
  • Pharmacodynamics:
    Antibacterial drug of a broad spectrum of action from the group of quinoxaline derivatives, has chemotherapeutic activity in infections caused by vulgar proteus, dysentery rod, Klebsiella, Pseudomonas aeruginosa, salmonella, staphylococcus, streptococcus, pathogenic anaerobes (including gas gangrene pathogens), acts on strains of bacteria, resistant to other chemotherapy drugs, including antibiotics.
    Possible development of drug resistance of bacteria. At intravenous introduction is characterized by small therapeutic breadth, in this connection strict observance of recommended doses is necessary. Treatment of burns and purulent-necrotic wounds promotes faster cleaning of the wound surface, stimulates reparative regeneration and marginal epithelization and favorably influences the course of the wound process.
    Pharmacokinetics:
    When topical application is partially absorbed from the wound or burns surface, it is excreted by the kidneys.
    After intravenous administration, the therapeutic concentration in the blood persists for 4-6 hours. It penetrates well into all organs and tissues and is excreted by the kidneys. TSta in the blood -1-2 hours after a single injection, with repeated administration does not cumulate. It is excreted by the kidneys.
    Indications:
    Purulent bacterial infections caused by sensitive microflora when other chemotherapeutic agents are ineffective or poorly tolerated.
    External application - superficial and deep wounds of various localization, long-term non-healing wounds and trophic ulcers, phlegmon soft tissues, infected burns, purulent wounds in osteomyelitis.
    Intracavitary injection - purulent processes in the thoracic and abdominal cavity, with purulent pleurisy, pleural empyema, lung abscess, peritonitis, cystitis, wounds with deep purulent cavities (abscesses of soft tissues, phlegmon of pelvic fat, postoperative wounds of urinary and bile ducts, purulent mastitis and other).
    Endotracheal administration - purulent tracheobronchitis.
    Intravenous administration - severe septic conditions (including patients with burn disease), purulent meningitis,severe purulent-inflammatory processes with symptoms of generalization of infection.
    Contraindications:
    • individual intolerance;
    • presence in the anamnesis of insufficiency of adrenal function;
    • pregnancy, lactation;
    • childhood;
    • with caution - kidney failure.
    Carefully:Renal insufficiency
    Pregnancy and lactation:The use is contraindicated.
    Dosing and Administration:
    Dioxydin is prescribed in a hospital. Apply externally, intravenously, intracaverally, endotracheally.
    External application. Apply 0.1% - 0.5% solutions of dioxidine. To obtain 0.1-0.2% solutions, ampoule solutions of the drug are diluted to the desired concentration with a sterile isotonic sodium chloride solution or water for injection. For the treatment of superficial infected purulent wounds on the wound, apply salfets moistened with 0.5% dioxygen solution. Deep wounds after treatment, loose plugging with tampons moistened with 0.5% dioxygen solution, and in the presence of a drainage tube, 20 to 100 ml of a 0.5% solution of the drug is injected into the cavity.
    For the treatment of deep purulent wounds with osteomyelitis (wounds of the hand,foot) apply 0.5% solution of the drug in the form of trays or special treatment of the wound with the solution of the drug for 15-20 minutes (insertion of the solution into the wound for this period), followed by application of dressings with a solution of dioxidine.
    Dioxydin in the form of 0.1-0.5% solutions can be used to prevent infection after surgery. According to the indications (patients with osteomyelitis) and with good tolerability treatment can be carried out daily for 1.5-2 months.
    Intracavitary injection. Depending on the size of the purulent cavity, 20% to 100 ml of a 0.5% solution (100-500 mg) of dioxidine are administered per day. Dioksidina solution is injected into the cavity through a catheter, drainage tube or syringe.
    The maximum daily dose for administration in the cavity of 140 ml of a 0.5% solution (700 mg). The drug is injected into the cavity usually once a day. According to the indications, it is possible to administer a daily dose in two divided doses. With good tolerability and the presence of indications, the drug can be administered daily for 3 weeks or more. If necessary, repeat courses are conducted after 1-1.5 months.
    Endotracheal administration. When diagnostic, sanative or therapeutic bronchoscopies use a 0.5% solution in an amount of 10-20 ml.For ultrasonic inhalations (in the treatment of purulent tracheobronchitis) a 0.5% solution is used in an amount of 10-20 ml.
    Intravenous administration. Dioxydin is injected into the vein with a drop method of 0.5% solution, which is diluted with 5% dextrose solution or 0.9% sodium chloride solution to a concentration of 0.1-0.2%. The daily dose of the drug is administered once or in 3-4 divided doses (fractional administration).
    Recommended doses of the preparation depending on the localization of the process:
    1. In the treatment of a purulent urinary tract infection, a daily dose of 200-400 mg of dioxidine, i.e. 40-80 ml of 0.5% solution;
    2. In chronic purulent processes in the lungs, the daily dose of 500-600 mg of dioxidine, i.e. 100-120 ml of a 0.5% solution;
    3. With purulent meningitis, a daily dose of 600-700 mg of dioxidine, i.e. 120-140 ml of 0.5% solution.
    4. In severe septic conditions, a 0.5% solution of the drug is injected intravenously intravenously, which is diluted in a 5% solution of dextrose or 0.9% solution of sodium chloride to a concentration of 0.1-0.2%. The daily dose of 600-900 mg (3-4 reception).
    Side effects:With intracavitary and intravenous administration, headache, chills, fever, dyspeptic disorders, convulsive muscle contractions, allergic reactions, photosensitizing effect (the appearance of pigmented spots on the body when exposed to sunlight) are possible.With external application - okoloranevoy dermatitis.
    Special instructions:
    Dioxydin is prescribed only to adults. Before the beginning of the course of treatment, a drug tolerance test is carried out, for which 10 ml of 0.5% solution is injected into the cavity. If there are no side effects during 3-6 hours (dizziness, chills, fever), course treatment begins.
    Dioxydin is prescribed only in severe forms of infectious diseases or in the ineffectiveness of other antibacterial drugs, including cephalosporins of II-IV generations, fluoroquinolones, carbapenems.
    In chronic renal failure, the dose is reduced.
    When pigmented spots appear, the duration of administration of the dose is increased to 1.5-2 hours, the dose is reduced, antihistamines are prescribed, or dioxygen is canceled.
    In the case of precipitation of crystals of dioxidine in ampoules with solution during storage (at a temperature below 15 ° C), they are dissolved by heating the ampoules in a boiling in the water bath with shaking until the crystals are completely dissolved (clear solution). If the crystals do not fall again upon cooling to 36-38 ° C, the preparation is usable.
    Form release / dosage:Solution for injection and topical application.
    Packaging:In ampoules of 5 or 10 ml in a package of 10 ampoules.
    Storage conditions:In the dark place at a temperature of 15about up to 25about
    Shelf life:2 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:P N003666 / 01
    Date of registration:20.08.2009
    Manufacturer: & nbsp
    Information update date: & nbsp18.03.2016
    Illustrated instructions
      Instructions
      Up